Project Details
Description
ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamid
| Status | Active |
|---|---|
| Effective start/end date | 5/21/20 → 12/31/27 |
Funding
- ALLIANCE FOUNDATION TRIALS, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.